Becton, Dickinson and Company (BDX) Shares Bought by Dorsey & Whitney Trust CO LLC

Dorsey & Whitney Trust CO LLC raised its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 1.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,675 shares of the medical instruments supplier’s stock after purchasing an additional 25 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in Becton, Dickinson and were worth $327,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the business. BlackRock Inc. increased its position in Becton, Dickinson and by 2,427.8% during the 1st quarter. BlackRock Inc. now owns 16,542,028 shares of the medical instruments supplier’s stock valued at $3,034,470,000 after purchasing an additional 15,887,611 shares during the period. Vanguard Group Inc. increased its position in Becton, Dickinson and by 5.3% during the 1st quarter. Vanguard Group Inc. now owns 15,902,168 shares of the medical instruments supplier’s stock valued at $2,917,094,000 after purchasing an additional 796,034 shares during the period. JPMorgan Chase & Co. increased its position in Becton, Dickinson and by 6.5% during the 1st quarter. JPMorgan Chase & Co. now owns 3,967,843 shares of the medical instruments supplier’s stock valued at $727,863,000 after purchasing an additional 242,081 shares during the period. Fiera Capital Corp increased its position in Becton, Dickinson and by 7.1% during the 2nd quarter. Fiera Capital Corp now owns 2,782,146 shares of the medical instruments supplier’s stock valued at $542,825,000 after purchasing an additional 183,372 shares during the period. Finally, Fundsmith LLP increased its position in Becton, Dickinson and by 3.2% during the 1st quarter. Fundsmith LLP now owns 2,296,613 shares of the medical instruments supplier’s stock valued at $421,291,000 after purchasing an additional 71,691 shares during the period. 87.12% of the stock is currently owned by institutional investors and hedge funds.

Shares of Becton, Dickinson and Company (BDX) opened at 196.29 on Wednesday. The company has a market cap of $44.67 billion, a PE ratio of 56.85 and a beta of 1.05. The stock’s 50 day moving average is $197.12 and its 200-day moving average is $192.80. Becton, Dickinson and Company has a one year low of $161.29 and a one year high of $206.63.

Becton, Dickinson and (NYSE:BDX) last announced its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, beating the consensus estimate of $2.44 by $0.02. The firm had revenue of $3.04 billion for the quarter, compared to analyst estimates of $3.06 billion. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The business’s revenue for the quarter was down 5.1% on a year-over-year basis. During the same quarter last year, the firm posted $2.35 earnings per share. Equities research analysts expect that Becton, Dickinson and Company will post $9.46 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, September 29th. Stockholders of record on Friday, September 8th were paid a dividend of $0.73 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $2.92 annualized dividend and a dividend yield of 1.49%. Becton, Dickinson and’s dividend payout ratio is currently 83.43%.

BDX has been the topic of a number of research analyst reports. Raymond James Financial, Inc. raised shares of Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and reduced their price objective for the company from $210.00 to $180.00 in a research report on Friday, June 30th. Cowen and Company reissued an “outperform” rating and set a $230.00 price objective (up from $200.00) on shares of Becton, Dickinson and in a research report on Monday, July 10th. BidaskClub raised shares of Becton, Dickinson and from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 11th. Zacks Investment Research raised shares of Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 price objective on the stock in a research report on Monday, July 17th. Finally, Bank of America Corporation reissued a “buy” rating and set a $225.00 price objective (up from $200.00) on shares of Becton, Dickinson and in a research report on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. Becton, Dickinson and has a consensus rating of “Buy” and a consensus target price of $200.93.

In other Becton, Dickinson and news, insider Ellen R. Strahlman sold 9,283 shares of Becton, Dickinson and stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $198.21, for a total value of $1,839,983.43. Following the transaction, the insider now owns 26,638 shares in the company, valued at $5,279,917.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas E. Polen, Jr. sold 5,971 shares of Becton, Dickinson and stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $197.41, for a total value of $1,178,735.11. Following the completion of the transaction, the insider now owns 12,861 shares in the company, valued at approximately $2,538,890.01. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 75,904 shares of company stock worth $15,242,688. Insiders own 1.40% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://sportsperspectives.com/2017/10/11/becton-dickinson-and-company-bdx-shares-bought-by-dorsey-whitney-trust-co-llc.html.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply